Cholinergic and inflammatory phenotypes in transgenic tau mouse models of Alzheimer’s Disease and Frontotemporal Lobar Degeneration
| dc.contributor.author | Cranston, Anna L | |
| dc.contributor.author | Wysocka, Adrianna | |
| dc.contributor.author | Steczkowska, Marta | |
| dc.contributor.author | Zadrozny, Maciej | |
| dc.contributor.author | Palasz, Ewelina | |
| dc.contributor.author | Harrington, Charles R | |
| dc.contributor.author | Theuring, Franz | |
| dc.contributor.author | Wischik, Claude | |
| dc.contributor.author | Riedel, Gernot | |
| dc.contributor.author | Niewiadomska, Grazyna | |
| dc.contributor.institution | University of Aberdeen.Medical Sciences | en |
| dc.contributor.institution | University of Aberdeen.Applied Medicine | en |
| dc.date.accessioned | 2020-08-06T10:00:00Z | |
| dc.date.available | 2020-08-06T10:00:00Z | |
| dc.date.issued | 2020-03-30 | |
| dc.description | All authors have made a substantial, direct and intellectual contribution to the work, and approved it for publication. This work was funded by NCN grant 2014/15/B/NZ4/05041 and WisTa Laboratories Ltd. CH and CW serve as officers in both WisTa Laboratories Ltd. and TauRx Therapeutics Ltd. The sponsor was involved in the design of the study; in the collection, analysis and interpretation of data; and in the writing of the report. The corresponding authors had full access to all the data and had final responsibility for submission of the report for publication. | en |
| dc.description.status | Peer reviewed | en |
| dc.format.extent | 17 | |
| dc.format.extent | 1276293 | |
| dc.identifier | 156645967 | |
| dc.identifier | 7b9242f4-4c51-4cbd-8519-21e1b65f899c | |
| dc.identifier | 32954291 | |
| dc.identifier | 85099053599 | |
| dc.identifier | 85099053599 | |
| dc.identifier | 85099053599 | |
| dc.identifier.citation | Cranston, A L, Wysocka, A, Steczkowska, M, Zadrozny, M, Palasz, E, Harrington, C R, Theuring, F, Wischik, C, Riedel, G & Niewiadomska, G 2020, 'Cholinergic and inflammatory phenotypes in transgenic tau mouse models of Alzheimer’s Disease and Frontotemporal Lobar Degeneration', Brain Communications, vol. 2, no. 1, fcaa033. https://doi.org/10.1093/braincomms/fcaa033 | en |
| dc.identifier.doi | 10.1093/braincomms/fcaa033 | |
| dc.identifier.iss | 1 | en |
| dc.identifier.issn | 2632-1297 | |
| dc.identifier.other | ORCID: /0000-0003-2250-3920/work/173415900 | |
| dc.identifier.uri | https://hdl.handle.net/2164/14871 | |
| dc.identifier.vol | 2 | en |
| dc.language.iso | eng | |
| dc.relation.ispartof | Brain Communications | en |
| dc.subject | SDG 3 - Good Health and Well-being | en |
| dc.subject | Alzheimer’s disease | en |
| dc.subject | cholinergic neurons | en |
| dc.subject | frontotemporal lobar degeneration | en |
| dc.subject | neuroinflammation | en |
| dc.subject | tau protein | en |
| dc.subject | R Medicine | en |
| dc.subject | Supplementary Data | en |
| dc.subject.lcc | R | en |
| dc.title | Cholinergic and inflammatory phenotypes in transgenic tau mouse models of Alzheimer’s Disease and Frontotemporal Lobar Degeneration | en |
| dc.type | Journal article | en |
Files
Original bundle
1 - 1 of 1
- Name:
- Cranston_etal_BC_Cholinergenic_VOR.pdf
- Size:
- 1.22 MB
- Format:
- Adobe Portable Document Format
